How do you interpret diagnostics and spatial biology — restructuring charges?

High charges indicate significant operational changes, which may lead to future margin improvements.

How does diagnostics and spatial biology — restructuring charges compare across companies?

Common in companies undergoing strategic pivots or cost-reduction programs.

Bio-Techne TECH Diagnostics And Spatial Biology — Restructuring Charges

Other segment segments

Protein Sciences

$2.12M+1,544%

Corporate

$688K+136%

Similar metrics at other companies

RVTYDiagnostics — Restructuring and Other Costs (Income)

$7.55M+5,496%

RVTYDiagnostics — Restructuring and contract termination charges, net

$1.12M+207%

CRLDSA — Restructuring Charges

$4.04M+2,366%

GTLSBiomedical — Restructuring Charges

$516K—

BIO.BClinical Diagnostics — Restructuring Charges

——

BIO.BLife Science — Restructuring Charges

——

Other financials

Income statement

See full

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

See full

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total equity$2.1B+3.3%

Total assets$2.6B-3.5%

Cash flow

See full

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Free cash flow$77.6M+150%

Valuation

See full

Market cap$9.07B-11.8%

Enterprise value$9.15B-13.6%

P/E60.6×+13.6×

P/S7.5×-1.0×

Profitability

See full

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

See full

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's diagnostics and spatial biology — restructuring charges.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Techne's diagnostics and spatial biology — restructuring charges?: Bio-Techne (TECH) reported diagnostics and spatial biology — restructuring charges of $27K in Q1 2026.
What does diagnostics and spatial biology — restructuring charges mean?: One-time costs incurred to reorganize or improve the efficiency of the segment's operations.
How do you interpret diagnostics and spatial biology — restructuring charges?: High charges indicate significant operational changes, which may lead to future margin improvements.
How does diagnostics and spatial biology — restructuring charges compare across companies?: Common in companies undergoing strategic pivots or cost-reduction programs.